Safety and efficacy of sofosbuvir-based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta-analysis.

Shaimaa Elshafie Rupal Trivedi-KapoorMark Ebell

Published in: Journal of clinical pharmacy and therapeutics (2022)

Our findings suggest nonsignificant differences in safety and efficacy between SOF-based medication regimens with and without RBV which should be considered in clinical practice.

Keyphrases

clinical practice
end stage renal disease
healthcare
ejection fraction
newly diagnosed
hepatitis c virus
chronic kidney disease
prognostic factors
patient reported outcomes